Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 mutations determined by targeted NGS in breast cancer: a case-control study

6 Sept 2021

Abstract excerpt

// Angeliki Andrikopoulou 1 , Evangelos Terpos 1 , Spyridoula Chatzinikolaou 1 , Kleoniki Apostolidou 1 , Ioannis Ntanasis-Stathopoulos 1 , Maria Gavriatopoulou 1 , Meletios-Athanasios Dimopoulos 1 and Flora Zagouri 1 1 Department of Clinical Therapeutics, Alexandra Hospital Medical School, Athens 11528, Greece Correspondence to: Flora Zagouri, email: florazagouri@yahoo.co.uk Keywords: TP53 mutations;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34676052
DOI: 10.18632/oncotarget.28071

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 mutations determined by targeted NGS in breast cancer: a case-control studyPMID 34676052Read ↗

Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine.Semantic proximity Read ↗

Targeted Next-generation Sequencing for Reliable Detection of Genetic Status in Breast Cancer.Semantic proximity Read ↗

Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.Semantic proximity Read ↗

Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing.Semantic proximity Read ↗

Germline TP53 pathogenic variants and breast cancer: A narrative review.Semantic proximity Read ↗

Identification of Somatic and Germline Mutations Influencing Treatment Outcomes and Disease Susceptibility in Tunisian Triple-Negative Breast Cancer Using Next-Generation Sequencing.Semantic proximity Read ↗

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.Semantic proximity Read ↗

The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing AnalysisSemantic proximity Read ↗

Tumor Profiling Using an NGS Cancer Hotspot Panel in Ukrainian Breast Cancer Patients: Initial Findings of Mutation Frequencies and Clinicopathologic Characteristics.Semantic proximity Read ↗

SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).Semantic proximity Read ↗

TP53 p.R337H Germline Variant among Women at Risk of Hereditary Breast Cancer in a Public Health System of Midwest Brazil.Semantic proximity Read ↗

Clinical Relevance of TP53 Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up DateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.